BenQ Medical Technology

BenQ Medical Technology OCF Margin

The Operating Cash Flow Margin of BenQ Medical Technology (4116.TWO) as of Nov 16, 2026 is 6.83 %. In the previous year, Operating Cash Flow Margin was 4.66 % — a change of 46.49% (higher).

OCF Margin

6.83 %

YoY

46.49%

Last updated:

Operating Cash Flow Margin of BenQ Medical Technology is 2025 6.83 % . Operating Cash Flow Margin of BenQ Medical Technology was 2024 4.66 % . It decreases by 46.49% higher compared to the previous year.

The BenQ Medical Technology OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
10.22 TWD
Jan 1, 2019
12.26 TWD
Jan 1, 2020
10.81 TWD
Jan 1, 2021
8.29 TWD
Jan 1, 2022
12.83 TWD
Jan 1, 2023
9.74 TWD
Jan 1, 2024
4.66 TWD
Jan 1, 2025
6.83 TWD
The BenQ Medical Technology OCF Margin history
YEAROCF MarginYoY
6.83 %+46.49%
4.66 %-52.13%
9.74 %-24.13%
12.83 %+54.90%
8.29 %-23.38%
10.81 %-11.80%
12.26 %+19.93%
10.22 %+45.33%
7.03 %-13.66%
8.15 %-11.39%
9.19 %-10.61%
10.29 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BenQ Medical Technology Stock analysis

What does BenQ Medical Technology do? BenQ Medical Technology Corp. generates revenue through the manufacturing, assembly, maintenance, repair, and sales of medical equipment and consumables. Its primary products include operating tables, out-patient check-in tables, surgical gloves, wound drainage sets, breathing tubes, breathing masks, gynecological examination tables, halogen surgical lights, LED lights, surgical room image and information integration systems, transfusion consumables, and portable ultrasonic wave products. The company distributes these products domestically and to overseas markets such as Asia, the Americas, and Europe, targeting hospitals, clinics, and healthcare facilities that require surgical and clinical equipment. The firm's product portfolio serves surgical rooms and various clinical examination rooms, with key items like halogen surgical lights, LED lights, and surgical room image and information integration systems being central to its offerings. Medical equipment sales drive revenue, focusing on both domestic and international healthcare providers across multiple regions. Products such as surgical gloves and wound drainage sets cater to routine clinical needs, while portable ultrasonic wave products support diagnostic applications in diverse medical settings. BenQ Medical Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BenQ Medical Technology stock

Operating Cash Flow Margin of BenQ Medical Technology is 6.83 % in 2025.

Operating Cash Flow Margin of BenQ Medical Technology changed from 4.66 % to 6.83 %, representing a 46.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin BenQ Medical Technology since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's BenQ Medical Technology with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — BenQ Medical Technology

All Key Metrics — BenQ Medical Technology